Company Overview
Snapshot
Founded in May 2018 by Ron Shimoni, Eden Firuz, and Oded Shoseyov, Seekwell operates with 1–10 employees. The company has raised $4 million across one funding round from one investor. In February 2022, Seekwell secured a significant investment from BOL Pharma.
Business overview
Seekwell is a Health Tech & Life Sciences company specializing in cannabis-based therapeutics. The company has developed a proprietary technology that leverages biochemical analysis and an AI-assisted process to match hemp-based formulations with specific medical and physical indications. Seekwell's platform aims to provide a stable supply chain for its partners while expanding the variety of indications targeted, serving markets such as the United States with products like Blosm.
Strategic signal
In February 2022, Seekwell received a $4 million investment from BOL Pharma, signaling strong investor confidence in its AI-assisted approach to cannabis-based therapeutics. This investment highlights the growing interest in precision medicine within the medical cannabis sector and validates Seekwell's potential to innovate in formulation matching for various medical conditions.
Log in to access full profile ›Company Intelligence Q&A
- When was Seekwell founded?
- Seekwell was founded in May 2018.
- Who are the founders of Seekwell?
- Seekwell was founded by Ron Shimoni, Eden Firuz, and Oded Shoseyov.
- What is Seekwell's primary focus?
- Seekwell focuses on developing cannabis-based therapeutics by matching hemp-based formulations to medical indications using AI-assisted biochemical analysis.
- Has Seekwell received any funding?
- Yes, Seekwell has raised $4 million across one funding round. In February 2022, the company received $4 million from BOL (Breath of Life) Pharma.
- What was a key product launch for Seekwell?
- In June 2021, Seekwell launched its first product, Blosm, which is specifically designed for women.